These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19920230)

  • 1. Biomarkers for prediction of cardiovascular events.
    Rosenstein RS; Parra D
    JAMA; 2009 Nov; 302(19):2089-90; author reply 2090. PubMed ID: 19920230
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for prediction of cardiovascular events.
    Cook NR
    JAMA; 2009 Nov; 302(19):2089; author reply 2090. PubMed ID: 19920231
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical activity, body mass index, and cardiovascular biomarkers in women.
    Cheng HY
    JAMA; 2006 Aug; 296(8):931-2; author reply 932. PubMed ID: 16926351
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease risk prediction factors.
    Williams K; Monroe HM
    JAMA; 2012 Nov; 308(19):1969-70; author reply 1970-1. PubMed ID: 23168815
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular disease risk prediction factors.
    Sniderman AD; Furberg CD
    JAMA; 2012 Nov; 308(19):1969; author reply 1970-1. PubMed ID: 23168814
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides and cardiovascular events: more than a stretch.
    Konstam MA
    JAMA; 2007 Jan; 297(2):212-4. PubMed ID: 17213406
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.
    Shah SH; de Lemos JA
    JAMA; 2009 Jul; 302(1):92-3. PubMed ID: 19567447
    [No Abstract]   [Full Text] [Related]  

  • 8. ["New" cardiovascular risk factors: will they emerge or will go down?].
    Mostaza JM; Lahoz C
    Med Clin (Barc); 2009 May; 132(18):704-5. PubMed ID: 19386330
    [No Abstract]   [Full Text] [Related]  

  • 9. Algorithms for assessing cardiovascular risk in women.
    Daniels LB; Ben-Yehuda O; Maisel AS
    JAMA; 2007 Jul; 298(2):177; author reply 177-8. PubMed ID: 17622598
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of emerging lipoprotein risk factors in assessment of cardiovascular risk.
    Grundy SM
    JAMA; 2012 Jun; 307(23):2540-2. PubMed ID: 22797454
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of cardiovascular disease events.
    Wilson PW
    Cardiol Clin; 2011 Feb; 29(1):1-13. PubMed ID: 21257097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept.
    Vlachopoulos C; Ioakeimidis N; Stefanadis C
    Asian J Androl; 2015; 17(1):17-20. PubMed ID: 25412676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) risk in women and efficacy of ascorbate.
    Bostom AG
    JAMA; 1994 Oct; 272(15):1169. PubMed ID: 7933344
    [No Abstract]   [Full Text] [Related]  

  • 14. Review on cardiovascular risk prediction.
    Ruwanpathirana T; Owen A; Reid CM
    Cardiovasc Ther; 2015 Apr; 33(2):62-70. PubMed ID: 25758853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?
    Lidani KC; Beltrame MH; Luz PR; Sandri TL; Nisihara RM; de Messias-Reaso IJ
    Int J Cardiol; 2015; 190():233-5. PubMed ID: 25920034
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
    Mora S; Lee IM; Buring JE; Ridker PM
    JAMA; 2006 Mar; 295(12):1412-9. PubMed ID: 16551713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels?
    Tanoglu A; Kara M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1126-9. PubMed ID: 26193051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.
    Bank IE; Timmers L; Gijsberts CM; Zhang YN; Mosterd A; Wang JW; Chan MY; De Hoog V; Lim SK; Sze SK; Lam CS; De Kleijn DP
    Expert Rev Mol Diagn; 2015; 15(12):1577-88. PubMed ID: 26535492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.